Chronic diastolic (congestive) heart failure
ICD-10 I50.32 is a billable code used to indicate a diagnosis of chronic diastolic (congestive) heart failure.
Chronic diastolic heart failure, also known as congestive heart failure with preserved ejection fraction (HFpEF), occurs when the heart's ventricles are unable to fill adequately with blood during diastole. This condition is characterized by symptoms such as shortness of breath, fatigue, and fluid retention, which can lead to pulmonary congestion and peripheral edema. The anatomy involved primarily includes the left ventricle, which becomes stiff and less compliant, affecting its ability to relax and fill with blood. Over time, chronic diastolic heart failure can progress due to underlying conditions such as hypertension, coronary artery disease, or diabetes, leading to worsening symptoms and increased hospitalizations. Diagnostic considerations include echocardiography to assess ventricular function, natriuretic peptide levels, and clinical evaluation of symptoms. Accurate diagnosis is crucial for effective management and treatment planning.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I50.32 covers chronic diastolic heart failure, which may be due to conditions such as hypertension, aortic stenosis, or hypertrophic cardiomyopathy. It is characterized by preserved ejection fraction and symptoms of heart failure.
I50.32 should be used when the patient exhibits symptoms of heart failure with preserved ejection fraction and when diagnostic tests confirm diastolic dysfunction. It is important to differentiate it from systolic heart failure (I50.31) based on echocardiographic findings.
Documentation should include clinical symptoms, results from echocardiograms indicating diastolic dysfunction, and any relevant laboratory tests such as BNP levels. Detailed patient history and treatment plans are also essential.
